# Clinical Benefits of B-Flow Ultrasound

Study · id `cardio:ct-nct02008097` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02008097](<https://clinicaltrials.gov/study/NCT02008097>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02008097

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 180 participants.

## Technical summary

Registry record NCT02008097. Non-randomized; no masking; primary purpose diagnostic. Start 2013-10 (actual); primary completion 2015-08-31 (actual). Results not posted.

## Key facts

- Design: Interventional study; non-randomized; no masking; primary purpose diagnostic
- Phase: Not applicable
- Enrolled: 180 participants (enrolled count; ClinicalTrials.gov record NCT02008097, source copy `cardio:ctgov-nct02008097-2018-05-01`, retrieved 2026-10-26)
- Started: 2013-10 (actual) (ClinicalTrials.gov record NCT02008097, source copy `cardio:ctgov-nct02008097-2018-05-01`, retrieved 2026-10-26)
- Primary completion: 2015-08-31 (actual) (ClinicalTrials.gov record NCT02008097, source copy `cardio:ctgov-nct02008097-2018-05-01`, retrieved 2026-10-26)
- Completion: 2015-09-01 (actual) (ClinicalTrials.gov record NCT02008097, source copy `cardio:ctgov-nct02008097-2018-05-01`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT02008097, source copy `cardio:ctgov-nct02008097-2018-05-01`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02008097-2018-05-01`, retrieved 2026-10-26)

## The registry's words

- Brief title: Clinical Benefits of B-Flow Ultrasound
- Condition: Evidence of Liver Transplantation
- Condition: Arterial Occlusive Diseases
- Condition: Hypertension
- Condition: Pregnancy, High Risk
- Condition: Pregnancy
- Intervention (Device): GE LOGIQ E9 Ultrasound System
- Lead sponsor: University of Washington
- Lead sponsor class: OTHER
- Collaborator: General Electric
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry lists this organization as the lead sponsor: University of Washington (`cardio:org-university-of-washington`)

## Provenance

Content hash: 0a343b276033196b9c095452983a2397c910fc0aaf00de26a0b8bbe7d7820041
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
